ClinicalTrials.gg
Not yet recruitingNCT06665191Updated Oct 30, 2024

Prevalence of Tooth Wear and Its Association with Oral Health-related Quality of Life

An observational study in Tooth Wear, Attrition and Erosion, sponsored by Cairo University. Not yet recruiting. Open to participants aged 31 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-30.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,011
Ages
31 Years to 45 Years
Sex
All
01

Study summary

The aim of this study is to detect the prevalence of tooth wear (All forms of cumulative surface loss of mineralized tooth substance loss due to physical and chemico-mechanical process according to the definition of the European Organization for Caries Research (ORCA) and the International Cariology Research Group for Dental Research (IADR) i.e.: attrition, erosion and abrasion) among middle aged adult patients attending educational hospital at the Faculty of Dentistry, Cairo University and to analyze the distribution of lesions by gender and age, frequency of acidic foods and drinks consumption, medicine usage, chewing habits, systemic diseases, tooth brushing habits, and family socio economic status. Moreover, to evaluate the quality of life among middle aged elderly patients in relation to existence of tooth wear.

The study focuses on middle-aged adult patients (31-45 years) attending the Faculty of Dentistry at Cairo University during 2025-2026. It is an analytical cross-sectional study aimed at assessing the prevalence and risk level of tooth wear using the Basic Erosive Wear Examination Index (BEWE). The BEWE categorizes tooth wear into four levels (0 = no wear, 3 = severe wear), and risk levels are determined by the cumulative score.

Primary outcome: the prevalence of tooth wear and associated risk levels. Secondary outcomes: identifying predictive risk factors and assessing the Oral Health Impact Profile (OHIP) for patients diagnosed with tooth wear. All participants will be examined, and those with a BEWE score above 0 will be considered affected. Risk levels will be stratified as no risk, low, medium, or high.

02

Conditions studied

  • Tooth Wear
  • Attrition
  • Erosion

Browse trials for

Keywords

  • Tooth wear
  • attrition
  • BEWE
  • Basic erosive wear examination
  • quality of life
03

In context

Tooth Wear

62 studies on the registry are indexed under Tooth Wear; 12 are open to participants now.

This study's planned enrollment of 1,011 is above the median of 71 across 21 observational studies indexed under Tooth Wear.

Browse Tooth Wear studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
31 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Middle aged adult patient attending educational hospital for dental treatments free of charfge

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1- Patients whose age between 31 to 45 years old. 2- Egyptian 3- Males \& Females 4- Provide 5- Ability to comprehend asked questions

Exclusion criteria

Exclusion Criteria:

  • 1- Patients under or over the selected age group 2- Patients using fixed orthodontic appliances, 3- Patients with special needs
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
1,011 participants (estimated)
Patient registry
No

Groups and cohorts

  • Middle aged Adults NOT suffering from dental wear

    Middle aged Adults NOT suffering from dental wear attending dental educational hospital in Cairo University

  • Middle aged adults Suffering from dental wear

    Middle aged adults Suffering from dental wear attending dental educational hospital in Cairo University

    Other: No Intervention: Observational study for prevalence of dental wear and its association with quality of life

Interventions

  • OtherNo Intervention: Observational study for prevalence of dental wear and its association with quality of life

    not applicable as it is an observational study testing the prevalence of dental wear in patients attending Cairo University

06

What researchers measure

Primary outcomes

  1. Prevalence and risk level of tooth wear

    Prevalence of wear will be tested using Basic erosive wear examination index (BEWE) 0 =no tooth wear 1. =minimal loss of surface texture 2. = distinct defect, hard tissue loss \<50% of the surface area 3. = hard tissue loss ≥ 50% of the surface area The examination is repeated for all teeth in a sextant but only the surface with the highest score is recorded for each sextant. To calculate prevalence Examined participants with score 0 will represent unaffected population % Examined participants with scores above 0 will represent the affected population % Stratification of risk levels will be done for affected population according to BEWE risk levels. The sum of the scores is calculated to provide the BEWE risk level (0-14) 0-2 = no risk 3-8= low risk 9-13= medium risk 14= high risk

    Time frame: 1 year

Secondary outcomes

  1. • Predictive risk factors for all participants using a questionnaire

    Sociodemographic data: age, gender, occupation and education Predictive risk factors: 1. Frequency of consuming acidic food and fruits, carbonated beverages and alcohol. 2. Medicine usage ( vitamin c, aspirin) 3. Chewing habits 4. Systemic diseases 5. Tooth brushing habits 6. Family socio economic status.

    Time frame: 1year

  2. Oral Health-Related Quality of Life (OHRQoL) using a questionnaire

    OHRQoL will be measured using Oral Health Index Profile (OHIP-14) questionnaire OHIP-14 is a 14-item questionnaire that measures : Functional limitation Physical pain Phycological discomfort Physical disability Social disability Phycological disability Handicap It measures responses on a Likert scale (0-4) with the following values: Never (0) Hardly ever (1) Occasionally (2) Frequently (3) Very frequently (4) Points for each response are summed so that each patient can score a minimum of 0 points and a maximum of 56 points. Low scores indicate better self-perceived quality of life, and high scores indicate worse self-perception of oral quality of life Participants diagnosed with tooth wear

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Oct 2026, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2024
First posted
Oct 30, 2024
StartEst.
Feb 2026
Primary completionEst.
Oct 2026
CompletionEst.
Nov 2026
Last update
Oct 30, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06665191
Lead sponsor
Cairo University
Responsible party
Omnia Abdel-Latif Amin (Assistant lecturer, Cairo University) — Principal investigator
First posted
Oct 30, 2024
Start date
Feb 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Oct 30, 2024

Study contacts

omnia Abdellatif omnia Abdellatif Amin, MSC. degree
Contact
omnia.abdellatif@dentistry.cu.edu.eg
+2 01272512839

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion